Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;96(2):E50-E53.
doi: 10.1002/ajh.26044. Epub 2020 Nov 21.

Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia

Guillermo Montalban-Bravo  1 , Rashmi Kanagal-Shamanna  2 , Veronica Guerra  1 , Jorge Ramos-Perez  1 , Danielle Hammond  1 , Paul Shilpa  3 , Kiran Naqvi  1 , Koji Sasaki  1 , Elias Jabbour  1 , Courtney DiNardo  1 , Koichi Takahashi  1 , Marina Konopleva  1 , Naveen Pemmaraju  1 , Tapan Kadia  1 , Farhad Ravandi  1 , Naval Daver  1 , Gautam Borthakur  1 , Zeev Estrov  1 , Joseph D Khoury  2 , Sanam Loghavi  2 , Sherry Pierce  1 , Carlos Bueso-Ramos  2 , Keyur Patel  2 , Hagop Kantarjian  1 , Guillermo Garcia-Manero  1
Affiliations
Free article

Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia

Guillermo Montalban-Bravo et al. Am J Hematol. .
Free article
No abstract available

Keywords: chronic myelomonocytic leukemia; clinical outcomes; mutational dominance; olygomonocytic.

PubMed Disclaimer

References

REFERENCES

    1. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405.
    1. Patnaik MM, Itzykson R, Lasho TL, et al. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients. Leukemia. 2014;28(11):2206-2212.
    1. Geyer JT, Tam W, Liu YC, et al. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia. Mod Pathol. 2017;30(9):1213-1222.
    1. Calvo X, Garcia-Gisbert N, Parraga I, et al. Oligomonocytic chronic myelomonocytic leukemia (O-CMML) and chronic myelomonocytic leukemia (CMML) show similar clinical, morphological, immunophenotypic and molecular features. Blood. 2019;134(suppl 1):4266.
    1. Such E, Germing U, Malcovati L, et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013;121(15):3005-3015.

Publication types

Substances

LinkOut - more resources